Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05427708

Respiratory Training in the Treatment of Transdiagnostic Pathological Anxiety

Respiratory Training in the Treatment of Transdiagnostic Pathological Anxiety: A Randomized Clinical Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
180 (estimated)
Sponsor
University of Texas at Austin · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Purpose of the Research: The primary aim of the proposed study is to conduct a randomized parallel-group 2-arm clinical trial investigating capnometry-guided respiratory intervention (CGRI) for pathological anxiety. CGRI aims to raise end-tidal CO2 levels thereby lowering hyperventilation-induced respiratory alkalosis and its associated fear-eliciting somatic reactions. Psycho-education about anxiety and its effects (PsyEd) will serve as a credible control comparator.

Detailed description

Low end-tidal CO2 (ETCO2), which is an accompanying feature of hyperventilation, has been associated with a variety of anxiety disorders, including panic disorder and social phobia. More recently, researchers have examined the efficacy of capnometry-guided respiratory intervention (CGRI) as a method for increasing ETCO2 and thereby reducing hyperventilation-induced anxiety/panic symptoms. Promising preliminary efficacy studies have shown that CGRI results in decreased panic symptom frequency and severity at a rate comparable to that of cognitive therapy. A recent uncontrolled proof-of-concept study showed that CGRI led to significant reductions in trauma symptoms in a sample of patients meeting DSM-5 criteria for PTSD. However, CGRI has not been adequately evaluated in the treatment of anxiety disorders other than panic disorder with or without agoraphobia.

Conditions

Interventions

TypeNameDescription
DEVICECapnometry-Guided Respiratory InterventionSee: Arm/group descriptions
BEHAVIORALPsycho-EducationSee: Arm/group descriptions

Timeline

Start date
2022-08-22
Primary completion
2027-05-01
Completion
2027-05-01
First posted
2022-06-22
Last updated
2025-08-24

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05427708. Inclusion in this directory is not an endorsement.